Neuropeptide Y in the central nucleus of the amygdala suppresses dependence-induced increases in alcohol drinking

Pharmacology Biochemistry and Behavior

Volumn 90, Issue 3, 2008, Pages 475-480

  Gilpin, Nicholas W ^a   Misra, Kaushik ^a   Koob, George F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Alcohol dependence; Alcohol withdrawal; Amygdala; Ethanol; Neuropeptide Y; Operant self administration

Indexed keywords

NEUROPEPTIDE Y;

ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DIETARY INTAKE; DRINKING BEHAVIOR; DRUG EFFECT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ALCOHOL DRINKING; ALCOHOLISM; AMYGDALA; ANIMALS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DATA INTERPRETATION, STATISTICAL; DIET; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; MALE; MICROINJECTIONS; NEUROPEPTIDE Y; RATS; STEREOTAXIC TECHNIQUES;

RATTUS; RATTUS NORVEGICUS;

EID: 44649182704     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.04.006     Document Type: Article

References (43)

1. Badia-Elder N.E., Stewart R.B., Powrozek T.A., Murphy J.M., and Li T.-K. Effects of neuropeptide Y on sucrose and ethanol intake and on the elevated plus maze test of anxiety in high alcohol drinking (HAD) and low alcohol drinking (LAD) rats. Alcohol Clin Exp Res 27 (2003) 894-899
2. Badia-Elder N.E., Stewart R.B., Powrozek T.A., Roy K.F., Murphy J.M., and Li T.-K. Effect of neuropeptide Y (NPY) on oral ethanol intake in Wistar, alcohol- preferring (P), and -nonpreferring (NP) rats. Alcohol Clin Exp Res 25 (2001) 386-390
3. Britton K.T., Southerland S., Van Uden E., Kirby D., Rivier J., and Koob G. Anxiolytic activity of NPY receptor agonists in the conflict test. Psychopharmacology 132 (1997) 6-13
4. Broqua P., Wettstein J.G., Rocher M.N., Gauthier-Martin B., and Junien J.L. Behavioral effects of neuropeptide receptor agonists in the elevated plus-maze and fear-potentiated startle procedure. Behav Pharmacol 6 (1995) 215-222
5. Davis M. The role of the amygdala in fear and anxiety. Annu Rev Neurosci 15 (1992) 353-375
6. Gilpin NW, Stewart RB, Badia-Elder NE. Neuropeptide Y administration into the amydala suppresses ethanol drinking in alcohol-preferring (P) rats following imposed ethanol abstinence. Pharmacol Biochem Behav 2008-this issue. doi:10.1016/j.pbb.2008.04.005
7. Gilpin N.W., Stewart R.B., Murphy J.M., and Badia-Elder N.E. Neuropeptide Y in the paraventricular nucleus of the hypothalamus increases ethanol intake in high- and low-alcohol-drinking rats. Alcohol Clin Exp Res 28 (2004) 1492-1498
8. Gilpin N.W., Stewart R.B., Murphy J.M., and Badia-Elder N.E. Sensitized effects of neuropeptide Y on multiple ingestive behaviors in P rats following ethanol abstinence. Pharmacol Biochem Behav 81 (2005) 740-749
9. Gilpin N.W., Stewart R.B., Murphy J.M., Li T.-K., and Badia-Elder N.E. Neuropeptide Y reduces oral ethanol intake in alcohol-preferring (P) rats following a period of imposed ethanol abstinence. Alcohol Clin Exp Res 27 (2003) 787-794
10. Heilig M., McLeod S., Brot M., Heinrichs S.C., Menzaghi F., Koob G.F., and Britton K.T. Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology 8 (1993) 357-363
11. Heilig M., McLeod S., Koob G.F., and Britton K.T. Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test. Regulat Pept 41 (1992) 61-69
12. Heilig M., Söderpalm B., Engel J.A., and Widerlöv E. Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology 98 (1989) 524-529
13. Hendry S.H., Jones E.G., DeFelipe J., Schmechel D., Brandon C., and Emson P.C. Neuropeptide-containing neurons of the cerebral cortex are also GABAergic. Proc Natl Acad Sci U S A 81 (1984) 6526-6530
14. Kash T.L., and Winder D.G. Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis. Neuropsychopharmacology 51 (2006) 1013-1022
15. Katner S.N., Slawecki C.J., and Ehlers C.L. Neuropeptide Y administration into the third ventricle does not increase sucrose or ethanol self-administration but does affect the cortical EEG and increases food intake. Psychopharmacology 160 (2002) 146-154
16. Katner S.N., Slawecki C.J., and Ehlers C.L. Neuropeptide Y administration into the amygdala does not affect ethanol consumption. Alcohol 28 (2002) 29-38
17. Kohler C., Eriksson L., Davies S., and Chan-Palay V. Neuropeptide Y innervation of the hippocampal region in the rat and monkey brain. J Comp Neurol 244 (1986) 384-400
18. Koob G.F. Alcoholism: allostasis and beyond. Alcohol Clin Exp Res 27 (2003) 232-243
19. Majchrowicz E. Induction of physical dependence upon ethanol and the associated behavioral changes in rats. Psychopharmacologia 43 (1975) 245-254
20. McBride W.J. Central nucleus of the amygdala and the effects of alcohol and alcohol-drinking behavior in rodents. Pharmacol Biochem Behav 71 (2002) 509-515
21. McDonald A.J., and Pearson J.C. Coexistence of GABA and peptide immunoreactivity in non-pyramidal neurons of the basolateral amygdala. Neurosci Letters 100 (1989) 53-58
22. 1-mediated mechanism. Eur J Neurosci 13 (2001) 2241-2246
23. Nie Z., Schweitzer P., Roberts A.J., Madamba S.G., Moore S.D., and Siggins G.R. Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors. Science 303 (2004) 1512-1514
24. Oberto A., Panzica G.C., Altruda F., and Eva C. GABAergic and NPY-Y1 network in the medial amygdala: a neuroanatomical basis for their functional interaction. Neuropharmacol 41 (2001) 639-642
25. Overstreet D.H., Knapp D.J., and Breese G.R. Similar anxiety-like responses in male and female rats exposed to repeated withdrawals from ethanol. Pharmacol Biochem Behav 78 (2004) 459-463
26. Pandey S.C., Zhang H., Roy A., and Xu T. Deficits in amygdaloid cAMP-responsive element-binding protein signaling play a role in genetic predisposition to anxiety and alcoholism. J Clin Invest 115 (2005) 2762-2773
27. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 4th ed. (1998), Academic Press, San Diego, CA
28. Primeaux S.D., Wilson S.P., Bray G.A., York D.A., and Wilson M.A. Overexpression of neuropeptide Y in the central nucleus of the amygdala decreases ethanol self administration in "anxious" rats. Alcohol Clin Exp Res 30 (2006) 791-801
29. Pu S., Jain M.R., Horvath T.L., Diano S., Kalra P.S., and Kalra S.P. Interactions between neuropeptide Y and γ-aminobutyric acid in stimulation of feeding: a morphological and pharmacological analysis. Endocrinology 140 (1999) 933-940
30. Rimondini R., Thorsell A., and Heilig M. Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence. Neurosci Lett 375 (2005) 129-133
31. Roberto M., Madamba S.G., Moore S.D., Tallent M.K., and Siggins G.R. Ethanol increases GABAergic transmission at both pre- and postsynaptic sites in rat central amygdala neurons. Proc Natl Acad Sci U S A 100 (2003) 2053-2058
32. Roberto M., Schweitzer P., Madamba S.G., Stouffer D.G., Parsons L.H., and Siggins G.R. Acute and chronic ethanol alter glutamatergic transmission in rat central amygdala: an in vitro and in vivo analysis. J Neurosci 24 (2004) 1594-1603
33. Sajdyk T.J., Schober D.A., and Gehlert D.R. Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats. Neuropharmacology 43 (2002) 1165-1172
34. Sajdyk T.J., Vandergriff M.G., and Gehlert D.R. Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test. Eur J Pharmacol 368 (1999) 143-147
35. Schroeder J.P., Olive F., Koenig H., and Hodge C.W. Intra-amygdala infusion of the NPY Y1 receptor antagonist BIBP 3226 attenuates operant ethanol self-administration. Alcohol Clin Exp Res 27 (2003) 1884-1891
36. Slawecki C.J., Betancourt M., Walpole T., and Ehlers C.L. Increases in sucrose consumption, but not ethanol consumption, following ICV NPY administration. Pharmacol Biochem Behav 66 (2000) 591-594
37. Stanley B.G., Chin A.S., and Leibowitz S.F. Feeding and drinking elicited by central injection of neuropeptide Y: evidence for a hypothalamic site(s) of action. Brain Res Bull 14 (1985) 521-524
38. Stewart R.B., Gatto G.J., Lumeng L., Li T.-K., and Murphy J.M. Comparison of alcohol-preferring (P) and nonpreferring (NP) rats on tests of anxiety and for the anxiolytic effects of ethanol. Alcohol 10 (1993) 1-10
39. Thorsell A., Repunte-Canonigo V., O'Dell L.E., Chen S.A., King A.R., Lekic D., et al. Viral vector-induced amygdala NPY overexpression reverses increased alcohol intake caused by repeated deprivations in Wistar rats. Brain 130 (2007) 1330-1337
40. Thorsell A., Slawecki C.J., and Ehlers C.L. Effects of neuropeptide Y on appetitive and consummatory behaviors associated with alcohol drinking in Wistar rats with a history of ethanol exposure. Alcohol Clin Exp Res 29 (2005) 584-590
41. Thorsell A., Slawecki C.J., and Ehlers C.L. Effects of neuropeptide Y and corticotropin-releasing factor on ethanol intake in Wistar rats: interaction with chronic ethanol exposure. Behav Brain Res 161 (2005) 133-140
42. Valdez G.R., and Koob G.F. Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism. Pharmacol Biochem Behav 79 (2004) 671-689
43. Valenstein E.S., Cox V.C., and Kakolewski J.W. Polydipsia elicited by the synergistic action of a saccharin and glucose solution. Science 157 (1967) 552-554